- PRKCI promotes immune suppression in ovarian cancer.
PRKCI promotes immune suppression in ovarian cancer.
Genes & development (2017-07-13)
Sharmistha Sarkar, Christopher A Bristow, Prasenjit Dey, Kunal Rai, Ruth Perets, Alejandra Ramirez-Cardenas, Shruti Malasi, Emmet Huang-Hobbs, Monika Haemmerle, Sherry Y Wu, Michael McGuire, Alexei Protopopov, Shan Jiang, Joyce F Liu, Michelle S Hirsch, Qing Chang, Alexander J Lazar, Anil K Sood, Ronny Drapkin, Ronald DePinho, Giulio Draetta, Lynda Chin
PMID28698296
ZUSAMMENFASSUNG
A key feature of high-grade serous ovarian carcinoma (HGSOC) is frequent amplification of the 3q26 locus harboring
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Sigma-Aldrich
Monoklonaler Anti-β-Aktin−Peroxidase-Antikörper der Maus in Maus hergestellte Antikörper, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Tumor Necrosis Factor-α antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-PRKCI antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution